Oxcarbazepine Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome mimicking septic shock;Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome à l'oxcarbazépine mimant un choc septique

Presse Medicale

Volumn 39, Issue 10, 2010, Pages 1103-1105

  Chakarian, Jean Charles ^a   Girault, Christophe ^b   Béduneau, Gaëtan ^b   Duval Modeste, Anne Bénédicte ^b   Joly, Pascal ^b   Bonmarchand, Guy ^b  

^a Centre Hospitalier De Dieppe   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; DROTRECOGIN; GELATIN SUCCINATE; HYDROCORTISONE SODIUM SUCCINATE; LEVOCETIRIZINE; OXCARBAZEPINE; OXYGEN; PREDNISONE; VANCOMYCIN; ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ADULT; ARTIFICIAL VENTILATION; CASE REPORT; DIARRHEA; DRESS SYNDROME; ENDOTRACHEAL INTUBATION; FULMINATING PURPURA; HUMAN; HYPERTHERMIA; LETTER; MACULOPAPULAR RASH; SEPTIC SHOCK; URTICARIA; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SHOCK, SEPTIC; SYNDROME;

ANTICONVULSANTS; CARBAMAZEPINE; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SHOCK, SEPTIC; SYNDROME;

EID: 77957359104     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.04.014     Document Type: Letter

References (12)

1. Coope R., Burrows R. Treatment of epilepsy with sodium diphenyl hydantoine. Lancet 1940, 1:490-492.
2. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersenstivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996, 15:250-257.
3. Tennis P., Stern R.S. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997, 49:542-546.
4. Hashizume H., Takigawa M., Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002, 168:5359-5368.
5. Sontheimer R.D., Houpt K.R. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998, 134:874-875.
6. Thorsten P., Josef M., Wolfram D. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000, 95:560-561.
7. Colvin J.H., Sheth A.P. Minocycline hypersensitivity syndrome with hypotension mimicking septic shock. Pediatr Dermatol 2001, 18:295-298.
8. Potter T. Dilantin hypersensitivity syndrome imitiating staphylococcal toxic shock. Arch Dermatol 1994, 130:856-858.
9. Pastor-Milan E., Rubert-Gomez M.A., Vazquez-Gutierrez F., Gonzalez V. Oxcarbazepine induced interstitial nephritis in a patient with drug hypersensitivity syndrome. Rev Neurol 2003, 37:948-950.
10. D'Orazio J.L. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Clin Toxicol (Phila) 2008, 46:1093-1094.
11. Bosdure E., Cano A., Roquelaure B., Reynaud R., Boyer M., Viard L., et al. Oxacarbazepine and DRESS syndrome: a pediatric cause of acute liver failure. Arch Pediatr 2004, 11:1073-1077.
12. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 1978, 2:1116-1118.